IDO1 and renal carcinoma: Furthermore, the combined administration of IDO inhibitor and IFN-α was shown to inhibit RENCA cell (renal cancer cell line in mice) while IFN-α or IDO inhibitor along couldn’t inhibit tumor growth (71).